Introduction
Drebrin, 'developmentally regulated brain protein', is an actin-binding protein which has been shown to stabilize actin filaments and link the actin cytoskeleton to the microtubular network. 1, 2 In mammals, a single Drebrin gene (Dbn1) transcript undergoes alternative splicing to produce two isoforms: adult (Drebrin A) and embryonic (Drebrin E). 3 Drebrin A is expressed in neurons, where it stabilizes actin filaments, thereby contributing to memory. 3, 4 Outside of the nervous system, Drebrin E expression has been reported in a variety of cell types. 5, 6 We previously found that Drebrin is abundantly expressed in smooth muscle cells (SMCs) and is up-regulated in response to arterial injury. 7 Using a model of global Drebrin haploinsufficiency, we previously found that Drebrin inhibits neointimal hyperplasia and outward remodelling (luminal diameter expansion) in response to wire-mediated carotid endothelial denudation. Consistent with a role in vascular inflammation, SMC Drebrin is up-regulated in atherosclerotic human arteries. 7 On a cellular level, Drebrin reduces SMC migration and proliferation through stabilization of actin filaments. 7 Hypertension is a highly prevalent chronic condition that results in vascular injury and remodelling, and is a major risk factor for the development of multiple cardiovascular diseases. Hypertensive fibroblasts. [8] [9] [10] An important contributor to hypertensive arterial remodelling is angiotensin II, 8, 11 which promotes hypertension and adverse arterial remodelling in a manner that varies by region of the arterial tree. 11, 12 Whereas angiotensin II-induced medial thickening involves SMC hypertrophy in the descending thoracic and abdominal aorta, it involves SMC hyperplasia in the ascending aorta. 12 Furthermore, angiotensin II promotes medial expansion independently of blood pressure (BP). 12 Angiotensin II signalling also contributes to the formation of thoracic and abdominal aortic aneurysms characterized by irreversible increases in luminal diameter, medial degeneration, extracellular matrix disruption, and inflammation. 13 Because our previous studies demonstrated that Drebrin reduces SMC activation, 7 we asked whether Drebrin expression in SMCs reduces remodelling in the ascending aorta in a model of angiotensin II-induced hypertension.
Methods
Detailed methods are available in the Supplementary material.
Results

Angiotensin II-induced hypertension in SMC-Dbn
À/À and Dbn flox/flox mice
We previously generated mice heterozygous for the presence of a trapping cassette upstream of floxed Drebrin exons 3-8. 7 Germline removal of the trapping cassette was achieved by mating Dbn -/þ mice heterozygous for the trapping cassette to mice expressing Flp recombinase in the C57BL/6 background ( Figure 1A ). Dbn flox/þ mice were mated with congenic C57BL/6 mice that express Cre recombinase under the control of the endogenous SM22 promoter 14 Figure S1A ). Because SM22 expression has been reported in multiple myogenic lineages during embryogenesis, 15 we immunoblotted adult heart and skeletal muscle extracts for Drebrin but found none in either Dbn flox/flox or SMC-Dbn -/-mice (Supplementary material online, Figure S1A ). Consistent with the known expression of SM22 in activated fibroblasts, 16 we also observed that Drebrin expression was deleted in activated adventitial fibroblasts from SMC-Dbn -/-mice in vitro (Supplementary material online, Figure S1B ).
To determine whether SMC Drebrin reduces angiotensin II-induced aortic remodelling, we used osmotic minipumps to infuse angiotensin II (1000 ng/kg/min) subcutaneously for 28 days. 17 In a pilot experiment, we found no difference in systolic BP between SMC-Cre and Dbn flox/flox mice assessed by tail cuff plethysmography 18 during a 28-day course of angiotensin II administration (Supplementary material online, Figure S2 ). Consequently, for subsequent studies involving radiotelemetry BP measurements, our control mice were Dbn flox/flox , which express WT levels of SMC Drebrin ( Figure 1B) . To measure BP continuously by radiotelemetry in conscious, unrestrained SMC-Dbn -/-and Dbn flox/flox mice, a pressure-sensing catheter was inserted via the left common carotid artery of anaesthetized mice as previously reported. 17 Ten days after catheter insertion, an osmotic minipump was implanted to infuse angiotensin II (1000 ng/kg/min) continuously for 28 days. 17 SMC-Dbn -/-and Dbn flox/flox mice were equivalent with regard to systolic BP, diastolic BP, and heart rate over the course of angiotensin II infusion (n = 7 per group, Figure 1C and D). Expression of the AT 1A angiotensin II receptor (AT 1A -R), which is responsible for angiotensin II-induced hypertension, 10 was equivalent in SMC-Dbn -/-and Dbn flox/flox aortas by qRT-PCR (Supplementary material online, Figure S3 ). Because Drebrin stabilizes F-actin in SMCs, 7 and because stabilization of F-actin can affect SMC contractility, 19 we sought to determine whether Drebrin affects angiotensin II-induced SMC contractility. To address this issue, we used infrarenal aortic rings from SMC-Dbn -/-and Dbn flox/flox mice. Tension generated by these rings was assessed using a calibrated force transducer, as previously described. 20 Tension generated by SMC-Dbn -/-and Dbn flox/flox mouse aortic rings was equivalent not only at baseline and in response to KCl but also in response to angiotensin II (Supplementary material online, Figure S4 ). Figure S5 ).
SMC Drebrin regulates angiotensin IIinduced remodelling in the ascending aorta
After 28 days of saline or angiotensin II infusion, mice were sacrificed and their aortas were harvested. There were no aneurysms (defined as a focal dilatation of more than 1.5 times of the normal outer aortic diameter) 21 in the thoracic or abdominal aortas of SMC-Dbn -/-, Dbn flox/flox or SMC-Cre þ mice (data not shown). We assessed vascular remodelling in the proximal ascending aorta, because in response to angiotensin II this aortic segment develops medial thickening resulting from SMC hyperplasia, 12 which is reduced by Drebrin activity. 7 Aortic dimensions were equivalent in saline-infused SMC-Dbn mice demonstrated 2.9 ± 0.2-fold more elastic lamina breaks than aortas from angiotensin II-infused control mice ( Figure 2E ). Ex vivo measurements of aortic lumen area accorded with ascending aortic diameter measurements made in vivo with echocardiography ( Figure  3A) ; however, the lumen area increment for SMC-Dbn -/-aortas was approximately 20% less when calculated from echocardiography-derived diameters than from direct histological measurement. Angiotensin IIinduced left ventricular hypertrophy ( Figure 3B ) and myocardial contractility assessed as fractional shortening ( Figure 3C ) were equivalent in SMCDbn -/-and control mice-concordant with the equivalence of angiotensin II-induced hypertension in SMC-Dbn -/-and control mice.
Whereas angiotensin II-induced medial thickening involves SMC hyperplasia in the ascending aorta, angiotensin II-induced medial thickening in the descending thoracic and abdominal aorta involves SMC hypertrophy. 12 For this reason, we examined the descending thoracic aorta and peripheral arteries to determine if Drebrin's effects on remodelling were specific to the proximal aorta. SMC-specific loss of Drebrin did not affect angiotensin II-induced medial thickening in the distal thoracic aorta (Supplementary material online, Figure S6 ) or in bronchial arteries (Supplementary material online, Figure S7 ). Thus, the effects of Drebrin on aortic remodelling are specific to the proximal ascending aorta, where angiotensin II-induced medial thickening involves SMC hyperplasia. 12 
SMC Drebrin limits SMC proliferation and extracellular matrix deposition
Angiotensin II-induced medial expansion in the ascending aorta involves both SMC proliferation and the deposition of extracellular matrix. 12, 22 As assessed by the prevalence of medial SMCs staining for proliferating cell nuclear antigen (PCNA), there was approximately two-fold more SMC proliferation in ascending aortas from SMC-Dbn -/-than from , and SMC-Dbn -/-mice were stripped of endothelium and adventitia, solubilized, and immunoblotted sequentially for Drebrin and then tubulin. The immunoblot shown is representative of three experiments performed with independent aortas. (C) Blood pressure in ambulatory mice was measured continuously by radiotelemetry using pressure-sensing catheters implanted in the common carotid artery. Ten days after pressure-sensing catheter insertion, osmotic minipumps were implanted to infuse angiotensin II (1000 ng/kg/min) continuously for 28 days. Shown are means ± S.E. for systolic blood pressure (blue) and diastolic blood pressure (red) over the course of angiotensin II infusion for SMC-Dbn -/-(n = 7) and Dbn flox/flox (n = 7) mice. (D) Heart rate in ambulatory mice was measured continuously by telemetry as in (C). Shown are means ± S.E. for heart rate (b.p.m.) over the course of angiotensin II infusion for SMC-Dbn -/-(n = 7) and Dbn flox/flox (n = 7) mice. Figure S8 ). Thus, excess angiotensin II-induced medial thickening in SMC-Dbn -/-ascending aortas involves not only increased SMC hyperplasia but also increased extracellular collagen deposition.
SMC Drebrin inhibits angiotensin IIinduced pro-inflammatory signalling
Outward remodelling results largely from aortic inflammation, 24 including inflammation associated with angiotensin II, which activates reactive oxygen species production and pro-inflammatory NFjB signalling not only in aortas but also in cultured SMCs. 25 In light of Drebrin's effects on angiotensin II-induced aortic remodelling, we sought to determine whether Drebrin affects angiotensin II-induced aortic inflammation. To determine the extent to which NFjB was activated in our aortas, we employed two read-outs: (i) NFjB p65 Ser536 phosphorylation, which augments NFjB transcriptional activity and is effected by IjB kinase-b and other kinases, 26, 27 and (ii) expression of vascular cell adhesion molecule-1 (VCAM-1, CD106), an integrin-binding protein that facilitates adhesion of monocytes, and that is encoded by an NFjB-dependent gene. 28 These excess adventitial macrophages may also augment degradation of elastic laminae in SMC-Dbn -/-aortas (Figure 2) , by secreting MMP-9 31 or cathepsin K. 32 Unlike monocyte/macrophages, mast cells were not more prevalent in SMC-Dbn -/-than in Dbn flox/flox aortas (Supplementary material online, Figure S10 ).
SMC Drebrin limits reactive oxygen species production
In response to angiotensin II, SMC-Dbn -/-aortas thus far have demonstrated greater SMC proliferation and inflammatory signalling than Dbn flox/flox aortas. Because SMC activation and proliferation are regulated, in part, by SMC NADPH oxidases, 33 we assessed aortic SMC NADPH oxidase activity by CellROX V R Orange and dihydroethidium staining ( Figure 6A-D) . Production of reactive oxygen species in ascending aortas of angiotensin II-infused mice was 1.7 ± 0.1-fold higher in SMC-Dbn -/-than in Dbn flox/flox mice ( Figure 6A and B). Thus, Drebrin activity in SMCs appears to reduce NADPH oxidase activity. NADPH oxidase activity augments pro-inflammatory signalling pathways 34 which, in a positive-feedback manner, further enhance expression of NADPH oxidases. 35 For this reason, we used qRT-PCR to quantitate aortic medial expression levels of NOX1 and NOX4, the primary NADPH oxidases in the murine aorta. 36 Consistent with their higher level of NADPH oxidase activity, angiotensin II-treated SMC-Dbn -/-aortas expressed 3.2 ± 1.7-fold more NOX1 mRNA than angiotensin IItreated Dbn flox/flox aortas, even though they expressed equivalent levels of NOX4 ( Figure 6E ). Concordantly, NOX1 protein expression was 2.5 ± 0.7-fold greater in SMC-Dbn -/-aortas than in Dbn flox/flox aortas from angiotensin II-infused mice ( Figure 6F ). In SMC-Dbn -/-aortas, could their higher NADPH oxidase activity be responsible for their greater NFjB activation, assessed ( Thus, in vitro as in vivo, Drebrin activity in SMCs attenuated NFjB activation. However, when we inhibited NADPH oxidase with the cellpermeant NOX inhibitor VAS3947, 37 TNF-induced NFjB p65 Ser536 phosphorylation was abolished in both SMC-Dbn -/-and Dbn flox/flox SMCs.
Together, these data support a model in which the excess NADPH oxidase activity of SMC-Dbn -/-SMCs augments NFjB activation 34 and subsequent aortic inflammation.
Discussion
We found that mice lacking Drebrin specifically in SMCs developed increased angiotensin II-induced medial hypertrophy and outward remodelling in the ascending aorta. Aortic medial expansion in response to angiotensin II involves SMC hyperplasia or hypertrophy in a manner that varies by region of the aorta. 12 We previously observed that Drebrin inhibits SMC proliferation, both in vivo, in response to carotid endothelial denudation, and in vitro, in response to foetal bovine serum through its effects on stabilizing actin filaments. 7 In this study, we found that loss of SMC Drebrin results in increased SMC proliferation, extracellular matrix deposition, and pro-inflammatory signalling in response to angiotensin II in the proximal aorta where angiotensin II-induced medial thickening involves SMC hyperplasia, 12 but has no effect on the degree of angiotensin II-induced hypertension or medial thickening in the descending thoracic aorta and peripheral arteries, where angiotensin II-induced remodelling involves SMC hypertrophy. Together, these findings suggest that Drebrin influences the phenotype of 'synthetic/proliferative' SMCs. The complex effects of angiotensin II on aortic remodelling include its role in promoting oxidative stress, inducing SMC proliferation through mitogen-activated protein kinases, and enhancing pro-inflammatory NFjB signalling. 25, 38, 39 Excessive NFjB signalling has previously been implicated in the development of pathologic aortic dilation. 40, 41 Increased
NFjB activation in SMC-Dbn -/-aortas can be explained by Drebrin's role in limiting up-regulation of NOX1 expression in response to chronic angiotensin II treatment (Supplementary material online, Figure S11 ). Increased NFjB activation in SMC-Dbn -/-aortas may also be explained by Drebrin's role in stabilizing actin filaments, 7 because NFjB signalling is regulated in part by the actin cytoskeleton: loss of smooth muscle a-actin or pharmacological disruption of actin filaments increases NFjB activation. 41, 42 SMC NADPH oxidase activity and inflammatory signalling are constrained not only by Drebrin but also by other F-actin-stabilizing proteins. Like deficiency of Drebrin, deficiency of SM22 increases production of reactive oxygen species and NFjB signalling. 34 In further parallels with Drebrin, SM22 also represses MMP-9 expression, through inhibition of ERK signalling and a reduction in AP-1-dependent transactivation of MMP-9 promoter activity. 29 Because our SMC-Dbn -/-mice harbour a knock-in of Cre recombinase that inactivates one native Sm22 allele, our SMC-Dbn -/-mice are haploinsufficient for SM22.
Nonetheless, our data demonstrate that the phenotype of SMC-Dbn -/- mice is not due to SM22 haploinsufficiency: our SMC-Cre (Sm22 -/þ ) mice were equivalent to Dbn flox/flox mice with regard to aortic medial thickening and luminal expansion (Figures 2 and 3) . Furthermore, SM22 haploinsufficient mice also phenocopy WT mice with regard to arterial neointimal hyperplasia evoked by endothelial denudation. 34 In addition to limiting up-regulation of NOX1 in response to angiotensin II, mechanisms through which Drebrin limits SMC NADPH oxidase activity may also involve endocytosis, a process that is inhibited by Drebrin 43 but required for NOX1 activation in SMCs stimulated by TNF. 44 Drebrin inhibits endocytosis via clathrin-coated pits and caveolae by associating with the actin-binding protein cortactin, and thereby preventing cortactin from binding to dynamin-2. 43 By binding to dynamin-2, cortactin scaffolds a ternary complex of cortactin/dynamin-2/actinrelated protein 3 (ARP3); this ternary complex promotes endocytosis through a process that involves growth of actin filaments. 45 Cortactin also mediates the interaction of the p47 phox subunit of the NADPH oxidase complex with the actin cytoskeleton 46, 47 -an interaction that is required for angiotensin II-induced NADPH oxidase activity. 47 Thus, by associating with cortactin, Drebrin may inhibit NADPH oxidase activity by inhibiting both endocytosis and the assembly of the NADPH oxidase complex. Angiotensin II-induced aortic remodelling involves SMC hyperplasia in the ascending aorta. 12 Interestingly, deletion of floxed angiotensin II type 1 A (AT 1A ) receptor alleles with an SM22-Cre transgene does not affect medial thickening of the ascending aorta. 10, 48 Instead, medial thickening of the ascending aorta is substantially reduced by deletion of floxed AT 1A receptor alleles with S100A4-driven Cre, specifically in fibroblasts-which populate not only the aortic adventitia but also the ascending aortic media of angiotensin II-treated mice, as demonstrated by lineage-tracing studies. 10 In the aortic media, these fibroblast-derived cells express smooth muscle a-actin, and thus assume a SMC-like phenotype. 10 Thus, medial expansion in the ascending aorta of angiotensin IItreated mice involves migration of fibroblasts from the adventitia to the media. 10 As adventitial fibroblasts migrate into the ascending aortic tunica media and trans-differentiate into SMC-like cells expressing SM22 in our SM22-Cre þ knock-in mice, we would expect these cells to express
Cre and thus to delete their floxed Dbn alleles. Indeed, we observed that Drebrin expression is deleted in activated adventitial fibroblasts from SMC-Dbn -/-mice in vitro (Supplementary material online, Figure S1B ).
Therefore, Drebrin may reduce angiotensin II-induced SMC proliferation and medial expansion in the ascending aorta by affecting trans-differentiating adventitial fibroblasts. It is also possible that Drebrin affects the response of medial SMCs to the migrating, trans-differentiating adventitial fibroblasts.
We have found that Drebrin suppresses angiotensin II-promoted aortic inflammation and remodelling. These findings raise the possibility that Drebrin activity may constrain aortic aneurysm formation, because angiotensin II signalling contributes to the formation of thoracic and abdominal aortic aneurysms. 49, 50 We did not observe thoracic or abdominal aneurysms in our study, likely because the incidence of aneurysm formation in C57BL/6 mice treated chronically with angiotensin II is low in the absence of a hypercholesterolaemic background or lysyl oxidase inhibition. 49, 50 Whether Drebrin deficiency would promote aortic aneurysm formation in these models remains to be determined.
Supplementary material
Supplementary material is available at Cardiovascular Research online. 
